Characteristics of the epidemic process of pertussis in Ukraine against the COVID-19 pandemic and martial law
DOI:
https://doi.org/10.15574/SP.2025.3(147).619Keywords:
whooping cough, morbidity, vaccine prophylaxis of pertussis, epidemic process, COVID-19, martial lawAbstract
In 1998, the World Health Assembly set a goal to reduce the incidence of pertussis to 1 case per 100,000 population. This target has not been achieved, and after the COVID-19 pandemic, the epidemic situation with pertussis has become more complicated for Ukraine and many countries.
The aim is to determine the epidemiological features of pertussis in Ukraine, taking into account the impact of the COVID-19 pandemic and martial law.
Materials and methods. The incidence of pertussis in Ukraine, its structure by age and territory, and vaccination coverage data were analyzed. A complex of epidemiological methods combined with mathematical statistics was applied.
Results and conclusions. After a sharp decrease in the incidence of pertussis in Ukraine against the backdrop of the COVID-19 pandemic in 2021-2022, it increased sharply in 2023-2024, which was complicated by martial law. A similar trend was observed in many other countries. The highest incidence rates were observed among children of the first year of life (362.15 per 100 thousand) and aged 1-4 years (114.13). This requires the introduction of revaccination against pertussis in children aged 6 years. During the epidemic upsurge in 2023-2024 the largest proportion of cases occurred in the western regions of Ukraine (73.8% and 53.4%, respectively), which were most involved in wartime migration processes and where vaccination coverage levels were low in previous years. The problem of pertussis losing the character of a vaccine-controlled infection requires further study, in particular, taking into account changes in the biological properties of Bordetella pertussis against the background of long-term vaccine prophylaxis.
References
ABC NEWS. (2024, Nov 8). Doctors call for whooping cough vaccination uptake amid worst year on record for cases. ULR: https://www.abc.net.au/news/2024-11-08/whooping-cough-surge-record-cases-2024-pertussis/104474394.
Amirthalingam G, Campbell H, Ribeiro S, Stowe J, Tessier E, Litt D et al. (2023). Optimization of timing of maternal pertussis immunization from 6 years of postimplementation surveillance data in England. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 76(3): e1129-e1139. https://doi.org/10.1093/cid/ciac651; PMid:35959786
Australian Immunisation Handbook. (2024, Aug 16). Pertussis (whooping cough). ULR: https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/pertussis-whooping-cough.
Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S et al. (2019). Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 24(7): 1700832. https://doi.org/10.2807/1560-7917.ES.2019.24.7.1700832; PMid:30782265 PMCid:PMC6381657
Ben Fraj I, Bouchez V, Smaoui H, Kechrid A, Brisse S. (2019). Genome characteristics of Bordetella pertussis isolates from Tunisia. Journal of medical microbiology. 68(9): 1320-1323. https://doi.org/10.1099/jmm.0.001042; PMid:31329091
Bhattacharyya S, Ferrari MJ, Bjørnstad ON. (2018). Species interactions may help explain the erratic periodicity of whooping cough dynamics. Epidemics. 23: 64-70. https://doi.org/10.1016/j.epidem.2017.12.005; PMid:29306640
Bhavsar A, Mertsola J, Poulsen A, Silfverdal SA. (2021). Pertussis in infants in Nordic countries. Acta paediatrica (Oslo, Norway : 1992). 110(7): 2040-2044. https://doi.org/10.1111/apa.15800; PMid:33555063
Bouchez V, Guillot S, Landier A, Armatys N, Matczak S et al. (2021). Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 26(37): 2001213. https://doi.org/10.2807/1560-7917.ES.2021.26.37.2001213; PMid:34533118 PMCid:PMC8447829
Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P. (2010). Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proceedings. Biological sciences. 277(1698): 3239-3245. https://doi.org/10.1098/rspb.2010.0994; PMid:20534609 PMCid:PMC2981935
Centers for Disease Control and Prevention. (2025, Jan 13). Pertussis Surveillance and Trends. ULR: https://www.cdc.gov/pertussis/php/surveillance/index.html.
Domenech de Cellès M, Magpantay FM, King AA, Rohani P. (2016). The pertussis enigma: reconciling epidemiology, immunology and evolution. Proceedings. Biological sciences. 283(1822): 20152309. https://doi.org/10.1098/rspb.2015.2309; PMid:26763701 PMCid:PMC4721090
Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P et al. (2019). Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines. Frontiers in immunology. 10: 1344. https://doi.org/10.3389/fimmu.2019.01344; PMid:31333640 PMCid:PMC6616129
European Centre for Disease Prevention and Control. (2024). Vaccine schedules in all countries in the EU/EEA. URL: https://vaccine-schedule.ecdc.europa.eu/.
European Centre for Disease Prevention and Control. (2024). Pertussis. Annual Epidemiological Report for 2022. ULR: https://www.ecdc.europa.eu/en/publications-data/pertussis-annual-epidemiological-report-2022.
European Centre for Disease Prevention and Control (2024, May 8). Rapid risk assessment. Increase of pertussis cases in the EU/EEA. URL: https://www.ecdc.europa.eu/sites/default/files/documents/Increase%20in%20pertussis%20cases%20in%20the%20EU-EEA%20-%20May%202024%20FINAL.pdf.
Guiso N, Soubeyrand B, Macina D. (2022). Can vaccines control bacterial virulence and pathogenicity? Bordetella pertussis: the advantage of fitness over virulence. Evolution, medicine, and public health. 10(1): 363-370. https://doi.org/10.1093/emph/eoac028; PMid:36032328 PMCid:PMC9400806
Guo S, Zhu Y, Guo Q, Wan C. (2024). Severe pertussis in infants: a scoping review. Annals of medicine. 56(1): 2352606. https://doi.org/10.1080/07853890.2024.2352606; PMid:38728617 PMCid:PMC11089926
Keeling MJ, Rohani P, Grenfell BT. (2001). Seasonally forced disease dynamics explored as switching between attractors. Physica D: Nonlinear Phenomena. 148(3-4): 317-335. https://doi.org/10.1016/S0167-2789(00)00187-1
Khalil A, Samara A, Campbell H, Ladhani SN, Amirthalingam G. (2024). Recent increase in infant pertussis cases in Europe and the critical importance of antenatal immunizations: We must do better…now. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 146: 107148. https://doi.org/10.1016/j.ijid.2024.107148; PMid:38960028
Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N et al. (2014). Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerging infectious diseases. 20(4): 626-633. https://doi.org/10.3201/eid2004.131478
Machado MB, Passos SD. (2019). Severe pertussis in childhood: update and controversy - systematic review. Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo. 37(3): 351-362. https://doi.org/10.1590/1984-0462/;2019;37;3;00006; PMid:31116241 PMCid:PMC6868560
Melnyk MN, Birkovskyi YuIe, Pavlov OV et al. (1976). Rozpovsiudzhennia ta epidemiolohichna kharakterystyka naivazhlyvishykh infektsiinykh khvorob liudyny v Ukrainskii RSR (1945-1972). Pyd red. Melnyk M.N., Birkovskyi Yu.Ie., Pavlov O.V., Korotych O.S., Shcherbak Yu.M., Zarytskyi A.M., Terekhov S.M. Kyiv: 382: 208-217.
Merdrignac L, Acosta L, Habington A, Garcìa Cenoz M, Pandolfi E, Fabiánová K et al. (2022). Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother's vaccination in pregnancy in infants aged 2-11 months. Vaccine. 40(44): 6374-6382. https://doi.org/10.1016/j.vaccine.2022.09.054; PMid:36182617 PMCid:PMC9589240
Nguyen HT, Rohani P. (2008). Noise, nonlinearity and seasonality: the epidemics of whooping cough revisited. Journal of the Royal Society, Interface. 5(21): 403-413. https://doi.org/10.1098/rsif.2007.1168; PMid:17878136 PMCid:PMC2607388
Nordholm AC, Emborg HD, Nørgaard SK, Nygaard U, Ronayne A, Nielsen LB et al. (2024). Pertussis epidemic in Denmark, August 2023 to February 2024. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 29(14): 2400160. https://doi.org/10.2807/1560-7917.ES.2024.29.14.2400160
Podavalenko AP, Nessonova TD, Zadorozhna VI, Hrytsenko LМ. (2021). Epidemiological analiysis of pertussis morbidity in Ukraine. Wiadomosci lekarskie (Warsaw, Poland : 1960). 74(7): 1628-1633. https://doi.org/10.36740/WLek202107114; PMid:34459763
Podavalenko AP, Zadorozhna VI, Mokhamed AM, Podavalenko OV, Holovchak HS. (2013). Porivnialna otsinka epidemichnoi sytuatsii z kashliuku na tli yoho imunoprofillaktyky v riznykh rehionakh Ukrainy. Profilaktychna medytsyna. 1-2(20): 35-43.
Polak M, Zasada AA, Mosiej E, Krysztopa-Grzybowska K, Witkowski L, Rzeczkowska M et al. (2019). Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination. Microbes and infection. 21(3-4): 170-175. https://doi.org/10.1016/j.micinf.2018.12.001; PMid:30580013
Polinori I, Esposito S. (2019). Clinical Findings and Management of Pertussis. Advances in experimental medicine and biology. 1183: 151-160. https://doi.org/10.1007/5584_2019_410; PMid:31359365
Principi N, Bianchini S, Esposito S. (2024). Pertussis Epidemiology in Children: The Role of Maternal Immunization. Vaccines. 12(9): 1030. https://doi.org/10.3390/vaccines12091030; PMid:39340060 PMCid:PMC11436108
Principi N, Litt D, Terranova L, Picca M, Malvaso C, Vitale C et al. (2017). Pertussis-associated persistent cough in previously vaccinated children. Journal of medical microbiology. 66(11): 1699-1702. https://doi.org/10.1099/jmm.0.000607; PMid:28984566
Rodrigues C, Bouchez V, Soares A, Trombert-Paolantoni S, Aït El Belghiti F, Cohen JF et al. (2024). Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 29(31): 2400459. https://doi.org/10.2807/1560-7917.ES.2024.29.31.2400459
Saedi S, Safarchi A, Moghadam FT, Heidarzadeh S, Nikbin VS, Shahcheraghi F. (2021). Fha Deficient Bordetella pertussis Isolates in Iran with 50 Years Whole Cell Pertussis Vaccination. Iranian journal of public health. 50(7): 1454-1462. https://doi.org/10.18502/ijph.v50i7.6636
Sandoval T, Bisht A, Maurice AS. (2023). The impact of COVID-19 and masking practices on pertussis cases at a large academic medical center (2019-2021). American journal of infection control. 51(7): 844-846. https://doi.org/10.1016/j.ajic.2022.11.012; PMid:36417951 PMCid:PMC9675934
Seppälä E, Bråthen Kristoffersen A, Bøås H, Frimann Vestrheim D, Greve-Isdahl M et al. (2022). Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998-2019. Vaccine. 40(23): 3142-3149. https://doi.org/10.1016/j.vaccine.2022.04.038; PMid:35469697
Sonneveld N, Wilson E, Ennis S, McRae J, Macartney K, Liu B. (2025). Patterns of reporting of influenza and pertussis vaccination during pregnancy to the Australian Immunisation Register. 2022: medRxiv 2025.01.23.25320512; https://doi.org/10.1101/2025.01.23.25320512
Wendelboe AM, Van Rie A, Salmaso S, Englund JA. (2005). Duration of immunity against pertussis after natural infection or vaccination. The Pediatric infectious disease journal. 24; 5 Suppl: S58-S61. https://doi.org/10.1097/01.inf.0000160914.59160.41; PMid:15876927
WHO. (1997). Health for All in the 21st Century. URL: https://applications.emro.who.int/docs/em_rc44_10_annex_en.pdf.
WHO. (2024, Jul 15). Immunization coverage. Key facts. ULR: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage.
Zomer A, Otsuka N, Hiramatsu Y, Kamachi K, Nishimura N, Ozaki T et al. (2018). Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines. Microbial genomics. 4(5): e000180. https://doi.org/10.1099/mgen.0.000180; PMid:29771235 PMCid:PMC5994715
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
